TSP-1 promotes glomerular mesangial cell proliferation and extracellular matrix secretion in Thy-1 nephritis rats☆

Wen Qiu, Yn Li, Jino Zhou, Chenhui Zho, Jing Zhng, Ki Shn, Dn Zho, Yingwei Wng*

aDepartment of Microbiology and Immunology, Nanjing Medical University, Nanjing, Jiangsu 210029, China;bSchool of Clinical Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China.

INTRODUCTION

Mesangioproliferative glomerulonephritis is a disease with a high incidence in humans[1]. Considerable evidence indicates that the proliferation of glomerular mesangial cells (GMC) in mesangioproliferative glomerulonephritis appears to be crucial in the secondary production of the mesangial extracellular matrix (ECM)[2,3]. Although the deposits of complement C5b-9 complexes have been shown in the glomeruli of patients with mesangioproliferative glomerulonephritis[4,5], the role of C5b-9 has not been fully understood until now. Rat Thy-1 nephritis is an animal model for human mesangioproliferative glomerulonephritis[6-8]. Thy-1 antibody can bind to Thy-1 antigen present on the GMC membrane, forming immune complexes, and then activate the complement system, causing GMC pathological lesions[9,10]. Several reports have demonstrated that renal pathological lesions in Thy-1 nephritis are C5b-9-dependent and neutrophil-independent[6,11,12].

It is well known that C5b-9 injury to nucleated cells is almost sublytic because cells can eliminate membraneinserted C5b-9 through endocytosis and/or shedding by homologous restriction factors. Sublytic C5b-9 attack can result in diverse events including cellular apoptosis, necrosis, proliferation and cytokine releases[13-16]. Early data from our experiments have confirmed that GMC proliferation and ECM production were markedly increased in GMC stimulated by sublytic C5b-9 in vitro[17,18], indicating that sublytic C5b-9, as a trigger, could play an important role in proliferative pathological changes in Thy-1 nephritis.

Thrombospondin-1 (TSP-1), as a multifunctional protein, plays essential roles in regulating cell proliferation and cell-ECM interaction[19-21]. During human and animal glomerulonephritis, TSP-1 is transiently highly expressed at sites of injury by various endogenous renal and inflammatory cell types[21-25]. Mounting evidence from previous studies suggests that TSP-1 can bind to transforming growth factor-β1 (TGF-β1) latent complexes, and then activate TGF-β1, which promotes the synthesis of matrix proteins[26]. Our published reports manifested that TSP-1 expression and TGF-β1 activation as well as GMC proliferation and ECM accumulation were increased in GMCs induced by sublytic C5b-9. Treatment of GMC with the GGWSHW peptide (a selective inhibitor of TSP-1) could block the interaction between TSP-1 and TGF-β1 and subsequent TGF-β1 activation as well as ECM production[17,18], and treatment of GMCs with TSP-1 small hairpin RNA (shRNA) could suppress GMC proliferation (data not shown), implying that TSP-1 could play a role in GMC proliferation and ECM secretion in GMCs exposed to sublytic C5b-9. However, the role of the TSP-1 gene in mediating GMC proliferation and ECM synthesis in renal tissues of Thy-1 nephritic rats has not been fully understood, although previous study showed that transfection with oligonucleotide against TSP-1 could inhibit glomerular ECM accumulation[27].

In the present study, the plasmids of TSP-1 shRNA (shTSP-1) were constructed and transfected into rat kidneys via renal artery perfusion followed by electroporation, and then anti-Thy-1 antibody was injected into the rats to induce Thy-1 nephritis. Corresponding experiments were then performed to determine the effects of TSP-1 gene knockdown on GMC proliferation and ECM production as well as urinary protein excretion in rats with Thy-1 nephritis.

MATERIALS AND METHODS

Reagents and animals

Polyclonal antibodies against cyclin D2, collagen IV and TSP-1, and monoclonal antibody against Thy-1 antigen (OX-7) and fibronectin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal antibody against proliferative cell nuclear antigen (PCNA) was supplied by Thermo (Fremont, CA, USA). Monoclonal antibody against β-actin, HRP-conjugated anti-mouse IgG antibody, 20×LumiGLO reagent® and 20×peroxide were purchased from Cell Signaling Technology (Danvers, USA). HRP-conjugated anti-goat IgG antibody and FITClinked anti-mouse IgG antibody were from Dako (Glostrup, Denmark) and KPL (Gaithersburg, MD, USA), respectively. 5-bromo-2-deoxyuridine (BrdU) was purchased from Sigma (St. Louis, MO, USA), and antibody against BrdU was from Thermo. The shRNA expression plasmids of pGCsi.U6.neo.RFP were from Genechem (Shanghai, China).

Rabbit polyclonal antibody against Thy-1 antigen was prepared according to previous documents[28,29]. Male Sprague-Dawley (SD) rats were from B&K Universal Ltd. (Shanghai, China). The animal study protocol was approved by the local institutional review board and carried out in accordance with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes for Health (NIH Publication No. 85-23, Revised 1996).

Construction of shRNA expression plasmids

To silence rat TSP-1 gene, we designed different shRNA sequences against TSP-1 (NM_001013062) mRNA. The expression plasmids of shTSP-1 were constructed by using pGCsi.U6.neo.RFP (XhoI and EcoRI). The most effective shRNA expression plasmids (CTCAATGAACGAGACAACT) against the TSP-1 gene were chosen for further experiments. Meanwhile, the control shRNA (shCTR) expression plasmids (CTTGCATTGCATCCTCATT) were produced as a negative control.

Establishment of Thy-1 nephritis model in rats and the experimental design

To confirm the roles of TSP-1 in mediating GMC proliferation and ECM secretion in Thy-1 nephritis, we randomly divided male SD rats (180-200 g) into 4 groups (n = 6 in each group), namely: 1) the Thy-1 nephritis group in which animals were given anti-Thy-1 antibody (0.75 mL/100 g body weight) by a single intraperitoneal injection; 2) the shTSP-1 + Thy-1 nephritis group; 3) the shCTR + Thy-1 nephritis group, and 4) the NS group in which the rats were injected intraperitoneally with normal rabbit serum (0.75 mL/100 g body weight). The rats allocated to group 2 and 3 were treated with modification as described previously[6]. The cortexes of rats were collected on d 7 after nephritis induction upon sacrifice. Red fluorescence protein (RFP) expression was observed to define the efficiency of transferring the plasmids into the kidneys (Fig. 1), and the efficiency of silencing TSP-1 gene expression was evaluated by immunoblotting assays. Part of renal tissues was also examined using immunoblotting analysis for the expression of cyclin D2, PCNA, fibronectin and collagen IV. In addition, the proliferative changes of GMC were determined by light and electron microscopy as well as by immunohistochemisty and immunofluorescence staining.

Fig. 1 The transfection efficiency of shRNA expression plasmids in vivo (Magnification: ×100; inset: ×400)

Immunoblotting assays

Rat renal tissues were lysed using the RIPA lysis buffer. Equal amounts (20 μg/lane) of protein were subjected to SDS-PAGE. Immunoblotting analysis was performed as described previously[6]. β-actin was used as an internal control of protein loading and the level of protein in each group was expressed relative to the control group.

BrdU incorporation analysis

To observe GMC proliferation of the rats with Thy-1 nephritis, we assessed glomerular cells by identification of cellular incorporation of BrdU into nuclear DNA. Beginning at 24 h prior to injection of anti-Thy-1 antibody, SD rats received an intraperitoneal injection of BrdU at a dose of 5 mg/100 g body weight every 12 h throughout disease progression to label proliferative cells[30-32]. BrdU uptake into the glomeruli was detected by immunofluorescence techniques as described below.

Immunohistochemical staining

Paraffin-embedded rat renal tissues were examined by immunohistochemical staining to determine the expression of TSP-1, PCNA and collagen IV and Thy-1 antigen (OX-7, as a marker of GMC). Firstly, sections (4 μm) were deparaffinized and incubated with purified antibodies. Then, the sections were incubated with HRP-conjugated secondary antibody, and were visualized via chromogen 3′-diaminobenzidine (DAB) staining. The number of glomerular PCNA- or OX-7-positive cells was counted in a double-blinded manner by observing 100 glomerular cross-sections from each rat, and was expressed as the mean number per glomerular cross-section as described previously[6].

Immunofluorescence staining

The frozen sections (4 μm) of rat renal tissues were stained with antibodies to BrdU, and then incubated with the corresponding fluorescein isothiocyanate (FITC)-conjugated secondary antibody. The number of glomerular BrdU-positive cells was detected according to the above-mentioned method. The number of glomerular BrdU-positive cells was expressed as the mean number per glomerular cross-section.

Proliferative change examination

For light microscopy, the histological sections (4 μm) of all renal cortex samples on d 7 after nephritis induction were stained with H&E, and 100 glomerular cross-sections from each rat were examined according to the same method[6]. For electron microscopy, ultrathin sections of all samples on d 7 were stained with uranyl acetate and lead citrate, and the ultrastructural changes were observed[28,33].

Urinary protein excretion

The urine samples of rats in different groups were collected on d 7 after the induction of nephritis. The contents of urinary protein (mg/24 h) of rats were measured by the total protein UC FS (DiaSys Diagnostic Systems, Holzheim, Germany).

Statistical analysis

Data are presented as mean±SD. One-way ANOVA was used to determine significant differences among groups. Where significant differences were found, individual comparisons were made between groups using the Student's t test and adjusting the critical value according to the Bonferroni method. P ＜ 0.05 was considered significant.

RESULTS

The effect of shTSP-1 on TSP-1 gene expression in the renal tissues of rats with Thy-1 nephritis

In order to explore the roles of TSP-1 gene activation in the pathological changes of Thy-1 nephritis in rats, we transfected the plasmids of shTSP-1 and sh-CTR respectively, into rat kidneys followed by Thy-1 nephritis induction. The rats were divided into following 4 groups: 1) the Thy-1 nephritis group; 2) the shTSP-1 + Thy-1 nephritis group; 3) the shCTR + Thy-1 nephritis group; 4) the NS group. The renal expression of TSP-1 protein in different groups of rats was examined on d 7 after Thy-1 nephritis induction, and the results showed that the expression of the TSP-1 gene was obviously increased in the renal tissues of Thy-1 nephritis rats, and that shTSP-1 could effectively reduce the expression of TSP-1 in the renal tissues of Thy-1 nephritis rats, while shCTR had no significant effect on renal TSP-1 expression (Fig. 2).

Fig. 2 The effects of shTSP-1 on renal TSP-1 expression in Thy-1 nephritis rats.

The roles of renal TSP-1 expression in GMC proliferation in rats with Thy-1 nephritis

To determine the roles of the TSP-1 gene in GMC proliferation of Thy-1 nephritis rats, we examined the levels of cyclin D2 and PCNA protein in the renal tissues of the above-mentioned rats on d 7, and the results manifested that shTSP-1, but not shCTR, could suppress the expression levels of cyclin D2 and PCNA (Fig. 3). Meanwhile, the number of proliferating glomerular cells and the total number of glomerular cells in the shTSP-1 + Thy-1 nephritis group were obviously lower than those in the shCTR + Thy-1 nephritis and Thy-1 nephritis groups (Fig. 4 and Fig. 5). It is worth mentioning that the changes of glomerular cell numbers were indeed due to the changes of GMC number because staining with anti-Thy-1 antibody (OX-7) was used to label GMC, and similar results were obtained (Fig. 6). On the other hand, the glomeruli of rats in the shTSP-1 + Thy-1 nephritis group exhibited less GMC proliferation relative to the shCTR + Thy-1 nephritis group and the Thy-1 nephritis group by electron microscopy (Fig. 7).

The roles of renal TSP-1 expression in mesangial ECM secretion in the glomeruli of rats with Thy-1 nephritis

The above-mentioned studies have shown that the renal expression of the TSP-1 gene was required for GMC proliferation in Thy-1 nephritis rats. To further evaluate the roles of the TSP-1 gene in ECM secretion of Thy-1 nephritis rats, the renal expression levels of fibronectin and collagen IV in the 4 groups were determined on d 7 after the induction of nephritis, and the results revealed that shTSP-1 treatment could remarkably inhibit the expression of fibronectin and collagen IV, while shCTR had no significant influence on it (Fig. 3). Meanwhile, electron microscopy revealed that the glomeruli of rats in the shTSP-1 + Thy-1 nephritis group showed less ECM accumulation within the mesangia of rats compared to the shCTR + Thy-1 nephritis group and Thy-1 nephritis group (Fig. 7).

Fig. 3 The effects of TSP-1 gene silencing on relative gene expression in Thy-1 nephritis rats.

Fig. 4 The effects of TSP-1 gene knockdown on the number of glomerular BrdU-positive cells inThy-1 nephritis rats (Original magnification: ×400).

Fig. 5 The effects of shTSP-1 on the number of glomerular cells in Thy-1 nephritis rats (Original magnification: ×400).

The effects of TSP-1 gene knockdown in renal tissues on urinary protein excretion of rats with Thy-1 nephritis

The effects of renal TSP-1 gene silencing on the excretion of urinary protein of Thy-1 nephritis rats were detected, and the results showed that shTSP-1 reduced the content of urinary protein (mg/24 h) of Thy-1 nephritis rats on d 7 after induction of nephritis compared with shCTR treatment (Fig. 8), implicating that inhibition of the renal TSP-1 gene could not only suppress proliferative pathologic changes, but also ameliorates the renal function of Thy-1 nephritis rats.

DISCUSSION

Human mesangioproliferative glomerulonephritis is a disease with a high incidence, and the proliferation of GMC in mesangioproliferative glomerulonephritis appears to be important in subsequent ECM deposition[1-3]. Rat Thy-1 nephritis is a typical animal model for studying human mesangioproliferative glomerulonephritis[6,7]. Administration of anti-Thy-1 antibody into rats binding to the surface of GMC can lead to complement system activation, resulting in GMC proliferation and ECM secretion during the process of Thy-1 nephritis[34,35]. However the mechanisms of GMC proliferation and ECM accumulation in Thy-1 nephritis rats have not been well elucidated.

Fig. 6 The effects of silencing the TSP-1 gene on GMC number in Thy-1 nephritis rats (Original magnification: ×400)

Fig. 7 The effects of shTSP-1 on GMC proliferation and ECM production in Thy-1 nephritis rats (Original magnification: ×5,000).

Fig. 8 The effect of shTSP-1 on urinary protein secretion (mg/24h) of Thy-1 nephritis rats.

The deposition of C5b-9, especially sublytic C5b-9 complexes, has been observed in the glomeruli of patients with mesangioproliferative glomerulonephritis and rats with Thy-1 nephritis[4,29], suggesting that sublytic C5b-9 could be involved in GMC pathological changes. Our previous studies have demonstrated that sublytic C5b-9 attack in vitro could cause obvious GMC proliferation and ECM production as well as TSP-1 production. Treatment of GMCs with the GGWSHW peptide (the selective inhibitor of TSP-1) could block the interaction between TSP-1 and TGF-β1 protein and subsequent TGF-β1 activation as well as ECM production[17,18], indicating that TSP-1 could activate TGF-β1 protein secreted by sublytic C5b-9-stimulated GMC, which in turn promoted ECM synthesis[18]. In addition, our previous studies showed that TSP-1 shRNA could suppress GMC proliferation induced by sublytic C5b-9 in vitro.

To reveal the roles of the TSP-1 gene in the renal proliferative damages of Thy-1 nephritis rats, shTSP-1 expression plasmids were transfected into rat kidneys followed by Thy-1 nephritis induction. Then, we observed the effects of TSP-1 gene knockdown in the renal tissues of rats on GMC proliferation and ECM expansion in Thy-1 nephritis rats. The results displayed that silencing of the TSP-1 gene could not only abolish GMC proliferation and but also suppress mesangial ECM deposition in Thy-1 nephritis rats, indicating that TSP-1 gene expression was involved in the proliferative lesions of Thy-1 nephritis rats. On the other hand, the effect of shTSP-1 on the urinary protein secretion of Thy-1 nephritis rats was determined, and the results showed that TSP-1 gene silencing could markedly reduce urinary protein secretion (mg/24 h) of Thy-1 nephritis rats, which was in agreement with the above-mentioned pathological changes.

Interestingly, the findings in our present study were not completely consistent with that in Daniel's study[27], as it was shown that the transfer of oligonucleotide against TSP-1 could inhibit glomerular ECM accumulation, but had no significant influence on GMC proliferation of Thy-1 nephritis rats. The difference between the two studies might explain that in our studies, and shTSP-1 expression plasmids were used and transferred into the kidneys on d 3 before induction of Thy-1 nephritis, but not on d 2 after Thy-1 nephritis induction. The suppression of renal TSP-1 gene ahead of the nephritis could affect some other factors or signaling transduction pathways, which could regulate GMC proliferation. Further studies need to be done exploring the mechanism through which TSP-1 regulates GMC proliferation in Thy-1 nephritis rats.

In conclusion, these findings confirm that TSP-1 gene expression was required for GMC proliferation and ECM secretion as well as urinary protein excretion in rat Thy-1 nephritis, which might provide novel insights into the pathogenesis of human mesangioproliferative glomerulonephritis.

Disclosure

All the authors declared no competing interests.

[1] Tumlin JA, Madaio MP, Hennigar R. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol 2007;2:1054-61.

[2] Darvill AM, Ballardie FW. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization. J Lab Clin Med 2006;147:301-9.

[3] Mestecky J, Suzuki H, Yanagihara T, Moldoveanu Z, Tomana M, Matousovic K, Julian BA, et al. IgA nephropathy: current views of immune complex formation. Contrib Nephrol 2007;157:56-63.

[4] Stangou M, Alexopoulos E, Pantzaki A, Leonstini M, Memmos D. C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scandinavian journal of urology and nephrology 2008;42:373-80.

[5] Turnberg D, Cook HT. Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens 2005;14:223-8.

[6] Qiu W, Che N, Feng X, Xia M, Wang H, Zhao D, Wang Y. Apoptosis of glomerular mesangial cells induced by sublytic C5b-9 complexes in rats with Thy-1 nephritis is dependent on Gadd45gamma upregulation. Eur J Immunol 2009;39:3251-66.

[7] Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. American journal of physiology 2010;298: F579-88.

[8] Nazeer K, Janech MG, Lin JJ, Ryan KJ, Arthur JM, Budisavljevic MN. Changes in protein profiles during course of experimental glomerulonephritis. American journal of physiology 2009;296:F186-93.

[9] Yamamoto T, Wilson CB. Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney international 1987;32:514-25.

[10] Yamamoto T, Wilson CB. Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 1987; 138:3758-65.

[11] Sato T, Van Dixhoorn MG, Prins FA, Mooney A, Verhagen N, Muizert Y, et al. The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis. J Am Soc Nephrol 1999; 10:1242-52.

[12] Brandt J, Pippin J, Schulze M, Hansch GM, Alpers CE, Johnson RJ, et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney international 1996; 49:335-43.

[13] Cudrici C, Niculescu F, Jensen T, Zafranskaia E, Fosbrink M, Rus V, et al. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. J Immunol 2006; 176:3173-80.

[14] Cole DS, Morgan BP. Beyond lysis: how complement influences cell fate. Clin Sci (Lond) 2003; 104:455-66.

[15] Fosbrink M, Niculescu F, Rus H. The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res 2005; 31:37-46.

[16] Fosbrink M, Niculescu F, Rus V, Shin ML, Rus H. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. The Journal of biological chemistry 2006; 281:19009-18.

[17] Gao L, Zhang Y, Qiu W, Xu WH, Feng XF, Ren J, et al. Effects of PI3-k/Akt short hairpin RNA on proliferation, fibronectin production and synthesis of thrombospondin-1 and transforming growth factor-beta1 in glomerular mesangial cells induced by sublytic C5b-9 complexes. Cell Prolif 2009;42:83-93.

[18] Gao L, Qiu W, Wang Y, Xu W, Xu J, Tong J. Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-beta1. Clin Exp Immunol 2006;144:326-34.

[19] Carlson CB, Lawler J, Mosher DF. Structures of thrombospondins. Cell Mol Life Sci 2008; 65:672-86.

[20] Lu Z, Kipnis J. Thrombospondin 1--a key astrocytederived neurogenic factor. Faseb J 2010; 24:1925-34.

[21] Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The role of thrombospondin-1 in human disease. J Surg Res 2004; 122:135-42.

[22] Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol 2004; 36:1115-25.

[23] Adams JC. Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling. Int J Biochem Cell Biol 2004; 36:1102-14.

[24] Zhang X, Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc Res 2007; 74:90-9.

[25] Hugo C, Daniel C. Thrombospondin in renal disease.

Nephron Exp Nephrol 2009; 111:e61-6.

[26] Lee HS, Song CY. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease. Histol Histopathol 2009; 24:901-8.

[27] Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. The American journal of pathology 2003; 163:1185-92.

[28] Xu JH, Qiu W, Wang YW, Xu J, Tong JX, Gao LJ, et al. Gene expression profile and overexpression of apoptosis-related genes (NGFI-B and Gadd 45 gamma) in early phase of Thy-1 nephritis model. Cell Tissue Res 2006; 326:159-68.

[29] Wang Y, He Q, Qin H, Xu J, Tong J, Gao L, et al. The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sci 2006; 79:182-92.

[30] Chen S, Turner S, Tsang E, Stark J, Turner H, Mahsut A, et al. Measurement of pancreatic islet cell proliferation by heavy water labeling. Am J Physiol Endocrinol Metab 2007; 293:E1459-64.

[31] Kimoto M, Yura Y, Kishino M, ToyosawaS, Ogawa Y. Label-retaining cells in the rat submandibular gland. J Histochem Cytochem 2008;56:15-24.

[32] Liu T, Wang CY, Gou SM, Wu HS, Xiong JX, Zhou J. PDX-1 expression and proliferation of duct epithelial cells after partial pancreatectomy in rats. Hepatobiliary Pancreat Dis Int 2007; 6:424-9.

[33] Plank C, Hartner A, Klanke B, Geissler B, Porst M, Amann K, et al. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis. Kidney international 2005; 68:1086-95.

[34] Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Ohashi R, Sugisaki Y, et al. Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis. Nephron 2000; 86:152-60.

[35] Beck S, Beck G, Ostendorf T, Floege J, Lambean G, Nevalainen T, et al. Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney international 2006;70:1251-60.